InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
0.8987
+0.0562 (6.66%)
Sep 4, 2026, 11:46 AM EDT - Market open
InspireMD Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10.84 | 8.98 | 7.01 | 6.21 | 5.17 | 4.5 | |
Revenue Growth | 53.42% | 28.11% | 12.96% | 20.00% | 15.04% | 80.88% |
Cost of Revenue | 8.88 | 6.33 | 5.5 | 4.4 | 4.05 | 3.74 |
Gross Profit | 1.96 | 2.65 | 1.51 | 1.81 | 1.12 | 0.75 |
Selling, General & Admin | 39.35 | 37.26 | 21.38 | 14.97 | 12.02 | 10.31 |
Research & Development | 16.17 | 15 | 13.63 | 7.98 | 7.81 | 5.16 |
Operating Expenses | 55.52 | 52.26 | 35.01 | 22.95 | 19.83 | 15.47 |
Operating Income | -53.56 | -49.61 | -33.5 | -21.14 | -18.71 | -14.72 |
Interest Expense | - | - | - | - | - | -0.16 |
Interest & Investment Income | 1.14 | 0.89 | 1.56 | 1.29 | 0.25 | - |
EBT Excluding Unusual Items | -52.42 | -48.72 | -31.95 | -19.85 | -18.46 | -14.87 |
Pretax Income | -52.42 | -48.72 | -31.95 | -19.85 | -18.46 | -14.87 |
Income Tax Expense | 0.06 | 0.06 | 0.06 | 0.07 | 0.03 | 0.05 |
Net Income | -52.48 | -48.79 | -32.01 | -19.92 | -18.49 | -14.92 |
Net Income to Common | -52.48 | -48.79 | -32.01 | -19.92 | -18.49 | -14.92 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 81 | 64 | 42 | 24 | 8 | 7 |
Shares Outstanding (Diluted) | 81 | 64 | 42 | 24 | 8 | 7 |
Shares Change | 63.52% | 53.42% | 72.77% | 208.29% | 7.16% | 385.71% |
EPS (Basic) | -0.65 | -0.76 | -0.76 | -0.82 | -2.35 | -2.03 |
EPS (Diluted) | -0.65 | -0.76 | -0.76 | -0.82 | -2.35 | -2.03 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -42.46 | -36.77 | -23.27 | -16.76 | -16.02 | -13.55 |
Free Cash Flow Per Share | -0.52 | -0.57 | -0.56 | -0.69 | -2.03 | -1.84 |
Gross Margin | 18.05% | 29.50% | 21.49% | 29.12% | 21.60% | 16.77% |
Operating Margin | -494.03% | -552.56% | -478.00% | -340.74% | -361.88% | -327.39% |
Profit Margin | -484.11% | -543.33% | -456.63% | -320.97% | -357.59% | -331.88% |
Free Cash Flow Margin | -391.67% | -409.45% | -332.00% | -270.06% | -309.71% | -301.54% |
EBITDA | -52.98 | -49.14 | -33.22 | -20.91 | -18.53 | -14.56 |
D&A For EBITDA | 0.58 | 0.48 | 0.28 | 0.23 | 0.19 | 0.16 |
EBIT | -53.56 | -49.61 | -33.5 | -21.14 | -18.71 | -14.72 |
Advertising Expenses | - | 1.6 | 0.69 | 0.43 | 0.36 | 0.29 |